RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0044-1792122
Early Diagnosis of Subclinical Atherosclerosis in Asymptomatic Type 2 Diabetic Normotensive Menopausal Women: A Global Pulse Wave Velocity Study
Funding None.
Abstract
Arterial stiffness serves as a cardiovascular disease marker, aiding in the early identification of high-risk patients. We aimed to evaluate the prevalence of arterial stiffness, measured by global pulse wave velocity (gPWV), among diabetic normotensive menopausal women (DPMW) and its correlation with levels of glycosylated hemoglobin (HbA1c). We recruited 641 consecutive DPMW diagnosed with type 2 diabetes over 5 years. The control group (CG) consisted of 300 normotensive, normoglycemic menopausal women. Normal gPWV was defined as a velocity ≤7.1 m/s. We enrolled 641 DPMW with a mean age of 57 ± 12 years. The CG comprised 300 normotensive, normoglycemic postmenopausal women with a mean age of 56 ± 4 years. Among DPMW, 29 (4.5%) exhibited increased gPWV compared with 4 (1.3%) in the CG (p < 0.01). Of the 225 (35.1%) DPMW with HbA1c > 7.5%, 23 (10.2%) had increased gPWV. In contrast, among the 416 (64.9%) DPMW with HbA1c < 7.5%, only 6 (1.4%) had increased gPWV (p < 0.0001). Electrocardiographic (ECG) abnormalities were detected in 208 (32.4%) DPMW, with 11 (5.3%) of them exhibiting increased gPWV (p = 0.6). There was a higher prevalence of increased gPWV in asymptomatic normotensive DPMW, with a significant association between increased gPWV and elevated HbA1c levels. However, there was no correlation between increased gPWV and abnormal ECG findings, despite ECG being the sole test recommended by current guidelines for all diabetic patients. Early detection of elevated HbA1c levels and increased gPWV may identify asymptomatic DPMW at higher cardiovascular risk, highlighting the inadequacy of a simple ECG in assessing cardiovascular risk in this population.
Keywords
menopausal women - normotensive - diabetes - atherosclerosis - early diagnosis - pulse wave velocity - arterial stiffnessPublikationsverlauf
Artikel online veröffentlicht:
04. November 2024
© 2024. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Maiello M, Cecere A, Zito A, Ciccone MM, Palmiero P. Arterial stiffness assessed by global pulse wave velocity in postmenopausal women affected by hypertension and/or metabolic syndrome: a global pulse wave velocity study. World Heart J 2021; 13 (04) 1-8
- 2 Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res 2021; 128 (07) 864-886
- 3 Regnault V, Lacolley P, Laurent S. Arterial stiffness: from basic primers to integrative physiology. Annu Rev Physiol 2024; 86: 99-121
- 4 Greenwald SE. Ageing of the conduit arteries. J Pathol 2007; 211 (02) 157-172
- 5 Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Arterioscler Thromb 1993; 13 (01) 90-97
- 6 Palmiero P, Maiello M, Daly Jr DD, Ciccone MM, Nanda NC. Aortic stiffness assessed by global pulse wave velocity in postmenopausal women: an ultrasonographic study. Echocardiography 2012; 29 (10) 1233-1238
- 7 Maiello M, Zito A, Ciccone MM, Palmiero P. How aortic stiffness in postmenopausal women is related to common cardiovascular risk factors. Cardiol Res Pract 2014; 2014: 216080
- 8 Kim GH. Primary role of the kidney in pathogenesis of hypertension. Life (Basel) 2024; 14 (01) 119
- 9 Zheng M, Zhang X, Chen S. et al. Arterial stiffness preceding diabetes: a longitudinal study. Circ Res 2020; 127 (12) 1491-1498
- 10 Death AK, Fisher EJ, McGrath KCY, Yue DK. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003; 168 (02) 263-269
- 11 Stehouwer CDA, Henry RMA, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 2008; 51 (04) 527-539
- 12 Prasad C, Davis KE, Imrhan V, Juma S, Vijayagopal P. Advanced glycation end products and risks for chronic diseases: intervening through lifestyle modification. Am J Lifestyle Med 2017; 13 (04) 384-404
- 13 Prenner SB, Chirinos JA. Arterial stiffness in diabetes mellitus. Atherosclerosis 2015; 238 (02) 370-379
- 14 Cohen JB, Mitchell GF, Gill D. et al. Arterial stiffness and diabetes risk in Framingham Heart Study and UK Biobank. Circ Res 2022; 131 (06) 545-554
- 15 Lebrun CEI, van der Schouw YT, Bak AAA. et al. Arterial stiffness in postmenopausal women: determinants of pulse wave velocity. J Hypertens 2002; 20 (11) 2165-2172
- 16 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55 (04) 613-618
- 17 Reichek N, Helak J, Plappert T, Sutton MS, Weber KT. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983; 67 (02) 348-352
- 18 Sotoda Y, Hirooka S, Orita H, Wakabayashi I. Paradox of the relationship between cardio-ankle vascular index and ankle-brachial index in patients with lower extremity artery disease. Ann Vasc Dis 2023; 16 (04) 253-260
- 19 Anagnostis P, Lambrinoudaki I, Stevenson JC, Goulis DG. Menopause-associated risk of cardiovascular disease. Endocr Connect 2022; 11 (04) e210537
- 20 Kamińska MS, Schneider-Matyka D, Rachubińska K, Panczyk M, Grochans E, Cybulska AM. Menopause predisposes women to increased risk of cardiovascular disease. J Clin Med 2023; 12 (22) 7058
- 21 Visseren FLJ, Mach F, Smulders YM. et al; ESC National Cardiac Societies, ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42 (34) 3227-3337
- 22 Cosentino F, Grant PJ, Aboyans V. et al; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020; 41 (02) 255-323
- 23
Marx N,
Federici M,
Schütt K.
et al;
ESC Scientific Document Group.
2023 ESC Guidelines for the management of cardiovascular disease in patients with
diabetes. Eur Heart J 2023; 44 (39) 4043-4140
MissingFormLabel
- 24 Pennells L, Kaptoge S, Østergaard HB. et al; SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J 2023; 44 (28) 2544-2556
- 25 Palmiero P, Zito A, Maiello M. et al. Left ventricular diastolic function in hypertension: methodological considerations and clinical implications. J Clin Med Res 2015; 7 (03) 137-144
- 26 McKay TB, Priyadarsini S, Karamichos D. Mechanisms of collagen crosslinking in diabetes and keratoconus. Cells 2019; 8 (10) 1239
- 27 Yoshida Y, Chen Z, Baudier RL. et al. Early menopause and cardiovascular disease risk in women with or without type 2 diabetes: a pooled analysis of 9,374 postmenopausal women. Diabetes Care 2021; 44 (11) 2564-2572
- 28 Stabley JN, Towler DA. Arterial calcification in diabetes mellitus: preclinical models and translational implications. Arterioscler Thromb Vasc Biol 2017; 37 (02) 205-217